Kunutsor: conceptualization, methodology, data curation, formal analysis, investigation, original draft, writingreview and editing
Summary: Wegovy (semaglutide) is not known to typically cause spotting, and this is not a recognised side effect
BPC-157 is also not an FDA-approved treatment, and they've noted safety concerns surrounding this peptide, citing that it may contain impurities and may trigger an unwanted immune system response that could be dangerous
Can I get tirzepatide for weight loss
Can phentermine help break a tirzepatide weight loss plateau
However, robust clinical research is needed to substantiate these claims